Klaviyo: Summit funds report 12.03% stake; 18,852,778 shares
Summit Partners-affiliated funds filed Amendment No. 5 to Schedule 13G reporting their beneficial ownership in Klaviyo, Inc. (KVYO).
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Summit Partners-affiliated funds filed Amendment No. 5 to Schedule 13G reporting their beneficial ownership in Klaviyo, Inc. (KVYO). The group reports an aggregate 12.03% of Klaviyo’s Series A Common Stock, calculated based on 137,856,147 Series A shares outstanding as of October 31, 2025, plus 18,852,778 Series A shares issuable upon conversion of their Series B shares.
The reported securities are held across several entities, including Fund IX-A with 11,142,414 Series A shares issuable (7.11%) and Fund IX-B with 6,957,168 issuable (4.44%), alongside smaller positions by Kiwi Co-Invest, Fund IX/VC IV, and Fund IX/VC IV (UK). Voting and dispositive powers are reported as shared in amounts corresponding to each fund’s position. The filing notes that certain principals may be deemed to share authority, while all parties disclaim beneficial ownership beyond their direct holdings.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake in Klaviyo (KVYO) do Summit Partners-affiliated funds report?
What are the largest individual fund positions disclosed for KVYO?
AI-generated analysis. How Rhea-AI works. Not financial advice.